The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Vardenafil Chanelle 10 mg Orodispersible Tablets

10 milligram(s) Orodispersible tablet

Chanelle MedicalPA0688/051/001

Main Information

Trade NameVardenafil Chanelle 10 mg Orodispersible Tablets
Active SubstancesVardenafil hydrochloride trihydrate
Strength10 milligram(s)
Dosage FormOrodispersible tablet
Licence HolderChanelle Medical
Licence NumberPA0688/051/001

Group Information

ATC CodeG04BE Drugs used in erectile dysfunction
G04BE09 vardenafil

Status

Authorised/WithdrawnAuthorised
Licence Issued19/01/2018
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back